Hitomi Jo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The inciting factor for bradycardia in COVID-19 patients: a potential harm of steroid treatment.
Journal: Journal of thoracic disease
Published: September 02, 2023
Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC.
Journal: JTO clinical and research reports
Published: November 21, 2022
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 03, 2022
Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancer.
Journal: Respiratory investigation
Published: September 10, 2021
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients.
Journal: Anticancer research
Published: September 07, 2021
Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations.
Journal: Molecular cancer therapeutics
Published: April 27, 2021
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2021
Clinical outcomes of pembrolizumab therapy in advanced-NSCLC patients with poor performance status (≥3) and high PD-L1 expression (TPS ≥50%): A case series.
Journal: Thoracic cancer
Published: August 16, 2020
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patient.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 09, 2020
Loxoprofen-induced interstitial pneumonia: a case report.
Journal: Journal of medical case reports
Published: January 13, 2016
Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.
Journal: Respiratory investigation
Published: January 04, 2016
Autoimmune pulmonary alveolar proteinosis with primary lung cancer in a patient of very advanced years.
Journal: Geriatrics & gerontology international
Published: April 23, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026